Treatment of gastric ulcer (GU).
Treatment of duodenal ulcer (DU).
Treatment of reflux esophagitis (RE) (erosive esophagitis EE).
Maintenance treatment of reflux esophagitis (erosive esophagitis) in patients with repeat recurrence and relapse of the condition. The duration of administration in the long-term efficacy clinical Study OCT-001 is up to 52 weeks.
Prevention of recurrence of gastric ulcer or duodenal ulcer during NSAIDs administration.
Adjunct to Helicobacter pylori eradication associated with: Gastric ulcer, duodenal ulcer, gastric MALT lymphoma, idiopathic thrombocytopenic purpura, the stomach after endoscopic resection of early stage cancer, or Helicobacter pylori gastritis.